SNCA and Mental deterioration: AQP‐4 dysfunction plays a pivotal role in glymphatic impairment, as demonstrated by animal models where AQP‐4 deletion exacerbates cognitive decline, beta‐amyloid accumulation, and alpha‐synuclein aggregation [44].